Journal of Biological Chemistry · 2004 · 36 citations · 27 references
Life SciencesBiochemistryMolecular BiologyProtein-protein InteractionsStructural BiochemistryStructural BiologyFibrous ProteinsMacromolecular InteractionsProtein StructureAmyloid Fibril FormationBinding AssaysC-terminal Domain StructureExon OrganizationLigand-binding AssaysMarfan Syndrome GeneticsProtein-ligand Binding AssaysYeast Two-hybrid Screening
Using yeast two-hybrid, ligand blotting, and solid phase binding assays, we have shown that microfibril-associated glycoprotein-1 (MAGP-1) interacts with the 8-cysteine motif of fibrillin-2 encoded by exon 24. Binding to this sequence was demonstrated for full-length MAGP-1 as well as for the MAGP-1 matrix-binding domain encoded by exons 7 and 8. The matrix-binding domain, but not the full-length protein, also bound to regions of fibrillin-2 defined by exons 16 and 17, exon 20, and exons 23 and 24. Interestingly, no binding was detected to sequences near the N or C terminus where MAGP-1 and MAGP-2, respectively, were shown to interact with fibrillin-1. The localization of MAGP-1 binding to the 8-Cys domain encoded by exon 24 suggests that the bead structure of microfibrils consists of exon 24 and portions of the central region of fibrillin-2. Exon 24 in fibrillin lies in the region of the molecule where mutations produce the most severe phenotypes associated with Marfan syndrome (fibrillin-1) and congenital contractural arachnodactyly (fibrillin-2). It is possible that these mutations alter the ability of fibrillin to bind MAGP-1, which may contribute to the severity of the disease. Using yeast two-hybrid, ligand blotting, and solid phase binding assays, we have shown that microfibril-associated glycoprotein-1 (MAGP-1) interacts with the 8-cysteine motif of fibrillin-2 encoded by exon 24. Binding to this sequence was demonstrated for full-length MAGP-1 as well as for the MAGP-1 matrix-binding domain encoded by exons 7 and 8. The matrix-binding domain, but not the full-length protein, also bound to regions of fibrillin-2 defined by exons 16 and 17, exon 20, and exons 23 and 24. Interestingly, no binding was detected to sequences near the N or C terminus where MAGP-1 and MAGP-2, respectively, were shown to interact with fibrillin-1. The localization of MAGP-1 binding to the 8-Cys domain encoded by exon 24 suggests that the bead structure of microfibrils consists of exon 24 and portions of the central region of fibrillin-2. Exon 24 in fibrillin lies in the region of the molecule where mutations produce the most severe phenotypes associated with Marfan syndrome (fibrillin-1) and congenital contractural arachnodactyly (fibrillin-2). It is possible that these mutations alter the ability of fibrillin to bind MAGP-1, which may contribute to the severity of the disease. Microfibrils are found in the extracellular matrices of most tissues where they serve several functional roles, including the binding and sequestration of growth factors, supplying informational signals through receptor signaling, and providing the basic structural elements for elastic fiber assembly. Many different proteins have been localized to microfibrils, although it is not clear whether all are structural proteins or proteins that simply associate with other components of microfibrils (1Kielty C.M. Shuttleworth C.A. Int. J. Biochem. Cell Biol. 1995; 27: 747-760Crossref PubMed Scopus (99) Google Scholar, 2Sherratt M.J. Wess T.J. Baldock C. Ashworth J. Purslow P.P. Shuttleworth C.A. Kielty C.M. Micron. 2001; 32: 185-200Crossref PubMed Scopus (73) Google Scholar). The fibrillins provide the basic functional framework of microfibrils. This multigene family consists of three related proteins (fibrillin-1, -2, and -3) that have a similar domain structure but differ in expression pattern and biological function (3Handford P.A. Downing A.K. Reinhardt D.P. Sakai L.Y. Matrix Biol. 2000; 19: 457-470Crossref PubMed Scopus (114) Google Scholar). The fibrillins are secreted from the cell as dimers that then pack together in ways that are not completely understood to form the microfibril. Extracted microfibrils are typically visualized as a linear string of beads with multiple arms extending into the interbead region. The beads show a ∼50-nm spacing, and several models of fibrillin assembly have been proposed to account for packing a 150-nm fibrillin monomer into a structure with 50-nm periodicity (4Reinhardt D.P. Keene D.R. Corson G.M. Poschl E. Bachinger H.P. Gambee J.E. J. Mol. Biol. 1996; 258: 104-116Crossref PubMed Scopus (208) Google Scholar, 5Baldock C. Koster A.J. Ziese U. Rock M.J. Sherratt M.J. Kadler K.E. Shuttleworth C.A. Kielty C.M. J. Cell Biol. 2001; 152: 1045-1056Crossref PubMed Scopus (122) Google Scholar). A second protein associated with microfibrils is a small molecular mass glycoprotein called microfibril-associated glyco-protein. MAGP-1 1The abbreviations used are: MAGP, microfibril-associated glycoprotein; EGF, epidermal growth factor; FBN, fibrillin; MBD, matrix-binding domain; SD, selective deficient (medium); Y2H, yeast two-hybrid; GST, glutathione S-transferase; CHO, Chinese hamster ovary. contains 183 amino acids that form two distinctive domains; the N-terminal half of the molecule is highly acidic, enriched in proline, and contains a clustering of glutamine residues, whereas the C-terminal portion contains all 13 cysteine residues and contains the matrix-binding domain that mediates the association of MAGP-1 with microfibrillar components (6Segade F. Trask B.C. Broekelmann T. Pierce R.A. Mecham R.P. J. Biol. Chem. 2002; 277: 11050-11057Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar). The protein undergoes post-translational transglutamination, sulfation of specific tyrosine residues, and O-linked glycosylation (7Trask B.C. Broekelmann T.J. Mecham R.P. Biochemistry. 2001; 40: 4372-4380Crossref PubMed Scopus (28) Google Scholar). In mouse development, MAGP-1 mRNA is widely expressed, mainly in mesenchymal and connective tissue cells where it is easily detected as early as day 8.5 of development (8Chen Y. Faraco J. Yin W. Germiller J. Francke U. Bonadio J. J. Biol. Chem. 1993; 268: 27381-27389Abstract Full Text PDF PubMed Google Scholar). MAGP-1 is associated with all microfibrils with only two known exceptions: those directly adjacent to the plasma membrane of aortic endothelial cells and those at the junction of the zonule and the lens capsule of the eye (9Henderson M. Polewski R. Fanning J.C. Gibson M.A. J. Histochem. Cytochem. 1996; 44: 1389-1397Crossref PubMed Google Scholar, 10Kumaratilake J.S. Gibson M.A. Fanning J.C. Cleary E.G. Eur. J. Cell Biol. 1989; 50: 117-127PubMed Google Scholar, 11Davis E.C. J. Cell Sci. 1994; 107: 727-736Crossref PubMed Google Scholar). MAGP-2 is a second member of the MAGP family that has close sequence similarity to MAGP-1 in a central region of 60 amino acids, where the spacing of 7 cysteine residues is identical in both proteins. The MAGP-2 molecule is otherwise rich in serine and threonine residues and lacks the proline-, glutamine-, and tyrosine-rich sequences characteristic of the N-terminal domain of MAGP-1 (12Gibson M.A. Hughes J.L. Fanning J.C. Cleary E.G. J. Biol. Chem. 1986; 261: 11429-11436Abstract Full Text PDF PubMed Google Scholar, 13Gibson M.A. Sandberg L.B. Grosso L.E. Cleary E.G. J. Biol. Chem. 1991; 266: 7596-7601Abstract Full Text PDF PubMed Google Scholar, 14Gibson M.A. Hatzinikolas G. Kumaratilake J.S. Sandberg L.B. Nicholl J.K. Sutherland G.R. Cleary E.G. J. Biol. Chem. 1996; 271: 1096-1103Abstract Full Text Full Text PDF PubMed Scopus (137) Google Scholar, 15Gibson M.A. Finnis M.L. Kumaratilake J.S. Cleary E.G. J. Histochm. Cytochem. 1998; 46: 871-885Crossref PubMed Scopus (79) Google Scholar). MAGP-2 exhibits a more restricted pattern of tissue localization and developmental expression than MAGP-1 (15Gibson M.A. Finnis M.L. Kumaratilake J.S. Cleary E.G. J. Histochm. Cytochem. 1998; 46: 871-885Crossref PubMed Scopus (79) Google Scholar), suggesting that MAGP-1 and MAGP-2 are structurally divergent proteins sharing one functional motif (encoded by two conserved exons) rather than being functionally closely related molecules. Both MAGPs have been shown to directly bind to purified fibrillin, and for MAGP-2, a prominent binding site was localized to a C-terminal region of fibrillin-1 containing seven tandem calcium-binding EGF-like repeats (16Penner A.S. Rock M.J. Kielty C.M. Shipley J.M. J. Biol. Chem. 2002; 277: 35044-35049Abstract Full Text Full Text PDF PubMed Scopus (61) Google Scholar). Preliminary mapping studies with MAGP-1 have localized putative binding sites near the N terminus (17Jensen S.A. Reinhardt D.P. Gibson M.A. Weiss A.S. J. Biol. Chem. 2001; 276: 39661-39666Abstract Full Text Full Text PDF PubMed Scopus (116) Google Scholar) and in the middle portion (18Trask B.C. Trask T.M. Broekelmann T. Mecham R.P. Mol. Biol. Cell. 2000; 11: 1499-1507Crossref PubMed Scopus (119) Google Scholar) of fibrillin-2, although these sites have not been mapped in great detail. In this study, we used a biochemical and molecular approach to precisely identify a prominent MAGP-1-binding site in fibrillin-2. The binding site maps to an 8-cysteine motif, encoded by exon 24, in a region of the fibrillin-2 molecule where mutations associated with the inherited disease congenital contractural arachnodactyly cluster. This is also the region where mutations in fibrillin-1 produce the most severe form of Marfan syndrome. Because MAGP-1 has been shown to reside on the bead structure of microfibrils (9Henderson M. Polewski R. Fanning J.C. Gibson M.A. J. Histochem. Cytochem. 1996; 44: 1389-1397Crossref PubMed Google Scholar), defining its binding site in fibrillin is important in discerning which part of the fibrillin molecule contributes to the bead. This information is critical for understanding the molecular packing that facilitates fibrillin assembly into a microfibril. Materials—A partial FBN2 cDNA was provided by Dr. Francesco Ramirez (Hospital for Special Surgery at Weill Medical College of Cornell University, Ithaca, NY). A bovine MAGP-1 cDNA was provided by Dr. Mark Gibson (University of Adelaide, Adelaide, Australia), and the human MAGP-1 cDNA is described in Segade et al. (6Segade F. Trask B.C. Broekelmann T. Pierce R.A. Mecham R.P. J. Biol. Chem. 2002; 277: 11050-11057Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar). Murine macrophage elastase was provided by Dr. Steven Shapiro (Harvard University, Boston, MA). Cell culture media and supplies were from commercial suppliers as indicated or from the Washington University Tissue Culture Support Center. The Matchmaker GAL4 Two-hybrid System 3 was purchased from Clontech. Restriction endonucleases and other enzymes were purchased from Promega or Roche Applied Science. All other reagents were obtained from and Two-hybrid were into the yeast expression the GAL4 The for the was from the expression (6Segade F. Trask B.C. Broekelmann T. Pierce R.A. Mecham R.P. J. Biol. Chem. 2002; 277: 11050-11057Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar) and into the yeast expression for the GAL4 and were used to cells the were on the selective and to for cells were on the selective The were at for The were and by The is as the the of in the by the of in and then as a of the obtained from the of and the and human with of the expression or in with the FBN2 or the were used as was as described by et al. R. Mol. Cell. Biol. 1998; PubMed Scopus Google Scholar). In FBN2 protein were by in of the used in the as described by the The ability of the to bind was by ligand by to region of FBN2 encoded by exons MAGP-1, and have been described (7Trask B.C. Broekelmann T.J. Mecham R.P. Biochemistry. 2001; 40: 4372-4380Crossref PubMed Scopus (28) Google Scholar, B.C. Trask T.M. Broekelmann T. Mecham R.P. Mol. Biol. Cell. 2000; 11: 1499-1507Crossref PubMed Scopus (119) Google Scholar, T.M. T.M. Broekelmann T. C. Mecham R.P. Biochem. J. PubMed Scopus Google Scholar). to fibrillin-2 exon 24 was the exon 24 protein described of the full-length bovine MAGP-1 expression in is described in Trask et al. (7Trask B.C. Broekelmann T.J. Mecham R.P. Biochemistry. 2001; 40: 4372-4380Crossref PubMed Scopus (28) Google Scholar). The and expression are described in Trask et al. T.M. T.M. Broekelmann T. C. Mecham R.P. Biochem. J. PubMed Scopus Google Scholar). the of FBN2 of the used for the of the expression and are from the the were used in to from human FBN2 cDNA were into the expression as indicated in the The of the was by for were purified from the of FBN2 in the expression of FBN2 in the were into the of to a with a N-terminal of phase cells in of at were to produce protein with the were with containing and and at for proteins were purified from the by binding to two with to the FBN2 proteins were from the with containing and of MAGP-1 and FBN2 in The of and full-length bovine MAGP-1 and the protein are described (18Trask B.C. Trask T.M. Broekelmann T. Mecham R.P. Mol. Biol. Cell. 2000; 11: 1499-1507Crossref PubMed Scopus (119) Google Scholar, T.M. T.M. Broekelmann T. C. Mecham R.P. Biochem. J. PubMed Scopus Google Scholar). of FBN2 in the the sequence was into the were by was by and into cells in for at cell which the was to cell and used to for protein expression were by of and proteins were by in was to the the proteins were from to for at in the were with in for at then with specific for and with The were with a of a in for and with the to the were on or and to as described The were with and in for at bovine MAGP-1 purified by was to the and the were for at The were and then with in for at protein was detected with in for at The were then three more with and the proteins were visualized with the was used to proteins by in Binding in cells were from culture or The proteins were in and to of 16 at the were three with of containing and 20, and binding sites were with in for at three with the were for at with of from the of the the were three with and for with an to MAGP-1 in binding three the were with a and and bound was detected with the System as described by the sequence and were with the of The in MAGP-1 to the N-terminal of the MAGP-1-binding site in fibrillin-2, we yeast to identify of fibrillin-2 and the The of MAGP-1, a region encoded by exons 7 and was shown in studies to the sequence in MAGP-1 of its microfibrils in the extracellular (6Segade F. Trask B.C. Broekelmann T. Pierce R.A. Mecham R.P. J. Biol. Chem. 2002; 277: 11050-11057Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar). The functional of the into the yeast expression for the GAL4 domain to a protein GAL4 that as from the N-terminal region of FBN2 were into the that for the GAL4 domain to proteins that were used as The ability of to protein was by in as described cells were with the MAGP-1 and a FBN2 and was by culture of the cells in selective that growth to those cells in which and the of we the shown in and in no functional was detected the and or cell growth and were from the the and and with the the Using of the we found that containing three domains; containing a domain by two domains; of the 8-cysteine domain by two domains; and the 8-cysteine domain by a domain, similar of cell growth and and Interestingly, no was detected the was exon 24 or exon 23 suggesting that the not interact with exon 24 in the a of yeast and ligand the of fibrillin-2 and the MAGP-1 matrix-binding domain is as the to the of in the by the of in and then to the obtained from the and is as or in ligand from in and of FBN2 with proteins are as or in a Two-hybrid by the we a ligand in which protein from the FBN2 by in was with of the of the in the used to the FBN2 to that were in containing of the proteins and of molecular were by in by the ligand the protein was to and with in FBN2 bound was detected by A of the shown in the of the detected by MAGP-1 to the N-terminal of provided information suggesting that the binding domain for MAGP-1 is in exons of fibrillin-2 but were not in the binding sequence in this region. the we used full-length MAGP-1 protein in ligand with a of FBN2 encoded by exons described in studies as T.M. Trask T.M. J. Mecham R.P. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). Both proteins were in cells and purified from the media as described purified protein molecular and with to was as a for the ligand its with MAGP-1 has been described Broekelmann T. Mecham R. Gibson M.A. Cleary E.G. J. Mecham R.P. J. Biol. Chem. 1994; Full Text PDF PubMed Google Scholar). as a for ligand the proteins were to and with purified full-length bovine were then used to MAGP-1 bound to the proteins. that MAGP-1 bound to both and but no was detected with the protein, of the of FBN2 and MAGP-1 to of MAGP-1 binding the purified protein was with mouse macrophage elastase a that FBN2 at a site the domain J.L. G. Rock M.J. Sherratt M.J. Shapiro Shuttleworth C.A. Kielty C.M. Biochem. J. PubMed Scopus Google Scholar). that two of and A small of was also with an to exon 24 that the the C-terminal portion of contains exons that the molecular mass is not a of the protein was demonstrated an a sequence in exon of fibrillin-2. the protein and were with this to with full-length MAGP-1 and with the MAGP-1 an MAGP-1 and the protein as well as the was no of MAGP-1 with the which contains the N-terminal sequences encoded by exons It is important to that MAGP-1 bound to that binding is of the of the that the of MAGP-1 and the was not to the of specific as a of mouse macrophage elastase we a containing exons of The protein was in by and used in a ligand with from the and assays, we were not to an and MAGP-1 the of a MAGP-1-binding site in the N-terminal region of fibrillin-2 of the MAGP-1-binding to FBN2 Exon 24 and ligand both that MAGP-1 fibrillin-2 at a site exons and the sequence for the we a of expression that the region. The in cells from the T.M. Trask T.M. J. Mecham R.P. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar), the In ligand assays, MAGP-1 was to bind the protein that the MAGP-1-binding site is exons and This region of the was into a expression and in cells indicated that the protein was that the MAGP-1-binding site was in this of FBN2 with the for the and of the region were then in and the purified proteins were by ligand that only the ability to bind full-length whether the that exon 24 in are for its binding to MAGP-1, as was found in the yeast we an expression that encoded of protein demonstrated that exon 24 the ability to bind MAGP-1 the of A second 8-cysteine domain, encoded by exons the MAGP-1-binding was in the ligand that MAGP-1 not interact with these the and ligand that the MAGP-1-binding domain is exon 24 of MAGP-1 interacts with the region exons of with an to fibrillin exon a to and with full-length bovine protein was then detected a MAGP-1 of and of a ligand of the proteins full-length MAGP-1 detected with an MAGP-1 a of The at the of the the domain structure of the three and whether or not they were with MAGP-1 on ligand or of molecular mass in is indicated on the of The were MAGP-1 to the 8-cysteine domain encoded by exon 24. and in and detected by with the fibrillin exon 24 or by ligand with full-length MAGP-1 was detected a MAGP-1 of molecular mass in is indicated on the The ability of exon 24 to bind MAGP-1 was also solid phase binding that full-length MAGP-1 bound to and whereas the not show binding the exon site and provide for the of a MAGP-1 domain in the N-terminal region of the fibrillin In this study, we used Y2H, ligand and solid phase binding as and to the MAGP-1-binding site in fibrillin-2. has been used by several to other extracellular including Keene D.R. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), the and the domain of J. Matrix Biol. 1998; PubMed Scopus Google Scholar), as well as the microfibrillar protein R. G. J. Biol. Chem. 2001; 276: Full Text Full Text PDF PubMed Scopus Google Scholar, in Scholar, in Scholar) and MAGP-2 (16Penner A.S. Rock M.J. Kielty C.M. Shipley J.M. J. Biol. Chem. 2002; 277: 35044-35049Abstract Full Text Full Text PDF PubMed Scopus (61) Google Scholar). In assays, provided a to binding sites but was not to identify the binding the containing the MAGP-1-binding was one of with Y2H, its specific binding were only by other not used with full-length MAGP-1 as MAGP-1 has the to and in the This was by only the matrix-binding domain of MAGP-1 as which in the and was to identify three MAGP-1 binding sequences in exons 16 and 17, exon 20, and exons 23 and 24. with full-length MAGP-1 the site of to the 8-cysteine domain in exon 24. 8-cysteine were in the assays, suggesting that is exon 24 and its ability to bind are several possible for the in binding sites detected by and the other The to the different of the two proteins used in the The used in the contains only two of the exons of MAGP-1 and may specific than the full-length protein used for the ligand and are more detected in the in a this in and may for exons 16 and 17, exon 20, and exons 23 and 24, whereas ligand only exon 24. The the and exons 16 and and exon may have biological that is to the full-length site in exon 24. studies have shown that the region exons and 24 of fibrillin is a site where several extracellular including and are known to bind (18Trask B.C. Trask T.M. Broekelmann T. Mecham R.P. Mol. Biol. Cell. 2000; 11: 1499-1507Crossref PubMed Scopus (119) Google Scholar, T.M. Trask T.M. J. Mecham R.P. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). This suggests that this region may a matrix-binding domain with multiple binding and It is that full-length MAGP-1 solid phase binding or the and with N-terminal that sequences shown by et al. (17Jensen S.A. Reinhardt D.P. Gibson M.A. Weiss A.S. J. Biol. Chem. 2001; 276: 39661-39666Abstract Full Text Full Text PDF PubMed Scopus (116) Google Scholar) to the MAGP-1-binding region in fibrillin-1. The amino sequences of fibrillin-1 and are highly through exon for the N terminus encoded by exon where the sequence is It is possible that the MAGP-1-binding site is in of fibrillin-1 but is from or fibrillin-2 of sequence A MAGP-1-binding site in exon with the studies of et al. (17Jensen S.A. Reinhardt D.P. Gibson M.A. Weiss A.S. J. Biol. Chem. 2001; 276: 39661-39666Abstract Full Text Full Text PDF PubMed Scopus (116) Google Scholar), MAGP-1 binding to a fibrillin-1 exons but binding to this region but exons The was also the fibrillin-1 C-terminal sequences shown by et al. (16Penner A.S. Rock M.J. Kielty C.M. Shipley J.M. J. Biol. Chem. 2002; 277: 35044-35049Abstract Full Text Full Text PDF PubMed Scopus (61) Google Scholar) to bind this was the sequence in the of MAGP-1 and we have shown in a that the binding of the two sequences are different of the of a for cysteine in the MAGP-2 sequence (6Segade F. Trask B.C. Broekelmann T. Pierce R.A. Mecham R.P. J. Biol. Chem. 2002; 277: 11050-11057Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar). It is not known this the of MAGP-2 for EGF-like sequences as to the 8-Cys motif by The localization of MAGP-1 binding to the 8-Cys domain encoded by exon 24 has important for understanding assembly. have demonstrated that fibrillin-1 and in the Keene D.R. Corson G.M. Reinhardt D.P. Sakai L.Y. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, G. T. J. Reinhardt D.P. J. Biol. Chem. 2002; 277: Full Text Full Text PDF PubMed Scopus Google Scholar), suggesting that the molecular information fibrillin similar for both Because MAGP-1 has been localized to the bead region of microfibrils, that the bead consists of exon 24 and portions of the central region of fibrillin-2 by the central portion of All of the models of fibrillin assembly fibrillin in a to pattern the (4Reinhardt D.P. Keene D.R. Corson G.M. Poschl E. Bachinger H.P. Gambee J.E. J. Mol. Biol. 1996; 258: 104-116Crossref PubMed Scopus (208) Google Scholar, 5Baldock C. Koster A.J. Ziese U. Rock M.J. Sherratt M.J. Kadler K.E. Shuttleworth C.A. Kielty C.M. J. Cell Biol. 2001; 152: 1045-1056Crossref PubMed Scopus (122) Google Scholar, A.K. J.M. C.M. P.A. Cell. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar, Biochemistry. PubMed Scopus Google Scholar). is on which of the fibrillin molecule the on microfibrils. on mapping Reinhardt et al. (4Reinhardt D.P. Keene D.R. Corson G.M. Poschl E. Bachinger H.P. Gambee J.E. J. Mol. Biol. 1996; 258: 104-116Crossref PubMed Scopus (208) Google Scholar) proposed that the and C-terminal of fibrillin-1 are in and on of the and more central of the molecule are the Baldock et al. C. Koster A.J. Ziese U. Rock M.J. Sherratt M.J. Kadler K.E. Shuttleworth C.A. Kielty C.M. J. Cell Biol. 2001; 152: 1045-1056Crossref PubMed Scopus (122) Google Scholar), in have proposed a on mapping and that the central portion of the molecule at the bead. are most with this second Interestingly, all of the three MAGP-1-binding sites in studies are in the region that is by Baldock et al. as being part of the bead. It is important to that exon 24 in fibrillin lies in the region of the molecule where mutations produce the most severe phenotypes associated with Marfan syndrome (fibrillin-1) and congenital contractural arachnodactyly (fibrillin-2). It is possible that these mutations alter the ability of fibrillin to bind MAGP-1, which may contribute to the severity of the disease. MAGP-1 in assembly or of MAGP-1 and Broekelmann for
27
Mark A. Gibson, George Hatzinikolas, Jaliya Kumaratilake et al. · Journal of Biological Chemistry · 1996 · 153 citations · Full text